Molecular Simulations of Muscle AChR Agonist Binding Sites  by Chakraborty, Srirupa et al.
Tuesday, February 10, 2015 429aLigand-gated Channels II
2155-Pos Board B292
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Acetylcholine Receptors: A Key Determinant of Agonist Efficacy
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Isabel Bermudez.
Biological and Medical Sciences, Oxford Brookes University, Oxford,
United Kingdom.
The a4b2 nicotinic acetylcholine receptor (nAChR) is the most abundant
nAChR type in the brain, and this type plays a pivotal role in the reinforcing
and rewarding effects of nicotine. The a4b2 nAChR exists in alternate
(a4b2)2 a4 and (a4b2)2b2 forms, which are activated by agonists with strik-
ingly differing efficacies. Recent breakthroughs have identified an additional
operational agonist binding site in the (a4b2)2a4 nAChR that increases the
maximal responses to ACh.
In this study, we characterised the ligand selectivity of the individual agonist
sites of the (a4b2)2a4 nAChR to determine whether differences in agonist
selectivity influences agonist efficacy. Applying the substituted cysteine acces-
sibility method to individual agonist sites in concatenated (a4b2)2a4 receptors,
we determined the agonist selectivity of the agonist sites of the (a4b2)2a4 re-
ceptor. We show that (a) the rate of covalent modification of substituted cyste-
ines depends on the subunit interface at which the modification occurs and b)
that agonists such as sazetidine-A and TC-2559 are excluded from the site at
the a4/a4 interface. Given that additional binding to the agonist site in the
a4/a4 interface, increases ACh efficacy and that agonists excluded from the
agonist site at the a4/a4 interface behave as partial agonists, we conclude
that the ability to engage all agonist sites in (a4b2)2a4 nAChRs is a key deter-
minant of agonist efficacy. The findings add another level of complexity to the
structural mechanisms that govern agonist efficacy in heteromeric nAChRs and
related ligand gated ion channels.
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Desformylflustrabromine Potentiates High-Sensitivity a4b2 Receptors by
Increasing Channel Opening Rate
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Desformylflustrabromine (dFBr) is a positive allosteric modulator of a4b2
neuronal nicotinic receptors (nAChRs). Investigations of mechanisms of
nAChR modulators may facilitate the development of new therapeutic drugs
that offset or correct errors in signaling associated with Alzheimer’s disease,
nicotine addiction, and other disorders of cholinergic signaling. We made
steady-state, cell-attached patch-clamp recordings of 20 pS, high-sensitivity
(HS) human a4b2 receptors stably expressed in HEK-293 cells. We developed
6-state gating models from data acquired with 1 mM ACh with and without
1 mM dFBr. Models included two sequential ligand-binding reactions leading
to a desensitized state (C14C24C34D), and mono- and diliganded open-
ings (O1 and O2) from C2 and C3, respectively. Rate constants governing tran-
sitions between connected states were obtained by fitting single-channel data
to the model (constraints: C1/C2 ¼ 2,C2/C3 and C3/C2¼2,C2/C1)
using a maximum likelihood method implemented in QUB. dFBr increased
binding and unbinding rates for ACh (2.6- and 2-fold, respectively), the open-
ing rate (C3/O2) for diliganded receptors (4.8-fold), and the (microscopic)
desensitization rate (5.3-fold). Simulations of macroscopic responses to
concentration-jumps (range: 0.1 mM - 100 mM) revealed that the enhanced
rate into O2 yielded approximately 2 to 3-fold potentiation of peak currents
(maximal Popen in 100 mM ACh ¼ 0.29) despite the fact that potentiation
was blunted by the enhanced rate of desensitization. Moreover, at ACh concen-
trations above 10 mM, our data are consistent with the interpretation that poten-
tiation of HS receptor responses to dFBr arises not from modulation of ligand
binding rates, but from an increase in the rate of channel opening, correspond-
ing to a decrease in the latency to first opening and a reduction in the time to
peak current (ACh 23 ms; dFBr 8 ms) of simulated macroscopic responses.
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Is the AChR a Cuckoo-Clock? Local and Remote Interactions of the aM2-
3 Linker in Gating
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The aM2-3 linker of pentameric ligand-gated ion channels (18-residues in
AChRs) is at the interface of the extracellular and transmembrane domains,
which twist relative to each other early in the channel-opening process
(phi~0.7). Phi-analyses of mouse muscle AChRs indicate that residues in this
linker and those at the transmitter binding sites share a common, even-earlierposition in the gating transition state (phi~0.9). To understand the mechanism
for the similar behavior of these two separated regions (~30 A˚), whose combined
motions appear to trigger channel-opening, we used single-channel free-energy
mutant cycle analyses (A-A pairs) to measure the extents to which a-subunit
linker residues (265-268) interactwith other amino acids. The significant interac-
tions (>0.5 kcal/mol) were as follows (n pairs tested; energies in kcal/mol): i)
aloop2 (7), aE45-aP265 ~þ3.5 (positive is unfavorable); ii) acys-loop (2),
aV132-aS268 ~þ1; iii) agonist sites (3), aS268 and aY93 or aY198 showed
no coupling but the interaction with aY190 was ~-1.2 (favorable); iv)
intra-linker (4), no significant coupling; v) εloop9 (6), εG183-aS268 and
εG183-aT267~þ1.4; vi) εpre-M1 (1), εL221-aT267, no coupling. The large, un-
favorable interaction between aP265 and its loop 2 neighbor aE45 (~5 A˚
separation in GLIC) suggests that these side chains share a common energetic
environment that is perturbed by the gating conformational change (twist). The
long-distance, favorable interaction between aS268A in the linker and
aY190A at the agonist site is more surprising. We hope to elucidate a network
of apposed residues whose shared energy changes might be associated with the
twist. More importantly, we are exploring the possibility that there is a long-
distance energy transfer between the agonist binding site and transmembrane
domain via the backbone that is not by a cuckoo-clock-like mechanical linkage.
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We are attempting to design and control the agonist binding properties of mus-
cle acetylcholine receptors (AChRs). These hetero-pentamers have 2 trans-
mitter binding sites in the extracellular domain, at a-d and either a-g (fetal)
or a-ε (adult) subunit interfaces. We used computational modeling and MD
simulation to investigate the structural dynamics and energetics of these 3
different binding interfaces. Starting from an Aplysia AChBP crystal structure
(PDB id 2BYQ), we used homology modeling to build all-atom dimer and pen-
tamer models of the extracellular domain, and docked acetylcholine (ACh) as
the ligand. MD simulations (Charmm27) were run to obtain binding free en-
ergies at all 3 interfaces. The a-d and a-ε sites were found to be approximately
equivalent, but a-g provided ~33% more favorable binding energy, which is in
good agreement with experimental, single-channel electrophysiology results
(Nayak and Auerbach, PNAS 2013). In the model, the packing of five aromatic
residues is tighter, the tryptophan residues 149 and 55 are more orthogonal and
loop C less is flexible at a-g compared to the others. The dimer and pentamer
models gave similar binding energies, supporting the experimental observation
that the agonist sites behave independently. We are using the model as a tool, to
identify residues in the ε and d subunits that are responsible for the lower ACh
binding energy and, hence, to guide the wet-bench experiments. We targeted
nine amino acids that are homologous in d and ε but different in g, within 20
A˚ of the quaternary ammonium of ACh. In the pentamer simulations, swapping
all of these between a-d and a-g resulted in a full switch of the structures and
energies. We are testing various subsets of these mutations in order to suggest a
minimum construct that can be verified by using electrophysiology.
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Each neuromuscular AChR has 2 agonist binding sites located in the extra-
cellular domain, at ad and either aε (adult) or ag (fetal) subunit interfaces.
Though in most species g- is replaced by the ε-subunit during perinatal devel-
opment, the rationale for the subunit swap is little understood. We used single-
channel electrophysiology to measure the effects of mutations of 5 conserved
aromatic residues at each type of agonist site, with regard to their contribution
to the free energy of agonist binding to active vs. resting receptors (DGB1; in
mouse AChRs with only 1 functional binding site expressed in HEK cells).
The agonist binding sites in both adult and fetal AChRs operate independently.
For 4 different agonists (including ACh and choline) DGB1 is ~-2 kcal/mol
more favorable at ag compared to aε and ad. Of the aromatic residues, only
3 contribute to the DGB1 at the adult sites (aY190, aY198 and aW149),
whereas all 5 do so at ag (including aY93 and gW55). The non-a tryptophan
(W55) is a variable energy source that makes a huge contribution to DGB1 only
at ag, where it shapes the binding pocket by interacting with some of the a-sub-
unit aromatics. The hydroxyl and benzene groups of loop C residues aY190 and
aY198 behave similarly at all three kinds of site, but the benzene of aY93 con-
tributes to DGB1 only at ag. We are studying other residues on the non-a side of
